<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39337848</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2075-1729</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>25</Day></PubDate></JournalIssue><Title>Life (Basel, Switzerland)</Title><ISOAbbreviation>Life (Basel)</ISOAbbreviation></Journal><ArticleTitle>Treatment of Severe Asthma: Case Report of Fast Action of Mepolizumab in a Patient with Recent SARS-CoV-2 Infection.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1063</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/life14091063</ELocationID><Abstract><AbstractText>Asthma is one of the most common chronic inflammatory diseases of childhood with a heterogeneous impact on health and quality of life. Mepolizumab is an antagonist of interleukin-5, indicated as an adjunct therapy for severe refractory eosinophilic asthma in adolescents and children aged &gt;6 years old. We present the case of a 9 year-old boy with severe asthma who experienced several asthmatic exacerbations following a SARS-CoV-2 infection, necessitating therapy with short-acting bronchodilators, oral corticosteroids, and hospitalization. We follow the patient using validated questionnaires for the evaluation of asthma control: Children Asthma Control Test, Asthma Control Questionnaire, respiratory function tests, and evaluation of exhaled nitric oxide fraction. After 12 weeks from the start of therapy with mepolizumab, we found significant improvements in lung function, a reduction in the degree of bronchial inflammation, and improvements in quality of life. No asthmatic exacerbations have been reported since the initiation of treatment with mepolizumab. Respiratory infections, such as those related to SARS-CoV-2, represent a significant risk factor for exacerbations in patients with moderate to severe forms of asthma. In our experience, following new episodes of exacerbation, the initiation of treatment with mepolizumab has allowed us to improve asthma control and enhance the quality of life of patients from the first doses. Although mepolizumab showed promise in this child with severe asthma during SARS-CoV-2 infection, the results from this single case cannot be generalized. Further studies are needed to confirm its safety and effectiveness.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Indolfi</LastName><ForeName>Cristiana</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Woman, Child and of General and Specialized Surgery, University of Campania Luigi Vanvitelli, 80138 Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dinardo</LastName><ForeName>Giulio</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-9952-1206</Identifier><AffiliationInfo><Affiliation>Department of Woman, Child and of General and Specialized Surgery, University of Campania Luigi Vanvitelli, 80138 Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klain</LastName><ForeName>Angela</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-7823-2125</Identifier><AffiliationInfo><Affiliation>Department of Woman, Child and of General and Specialized Surgery, University of Campania Luigi Vanvitelli, 80138 Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Decimo</LastName><ForeName>Fabio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Woman, Child and of General and Specialized Surgery, University of Campania Luigi Vanvitelli, 80138 Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miraglia Del Giudice</LastName><ForeName>Michele</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-8369-5957</Identifier><AffiliationInfo><Affiliation>Department of Woman, Child and of General and Specialized Surgery, University of Campania Luigi Vanvitelli, 80138 Naples, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Life (Basel)</MedlineTA><NlmUniqueID>101580444</NlmUniqueID><ISSNLinking>2075-1729</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">FeNO</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">asthma</Keyword><Keyword MajorTopicYN="N">case report</Keyword><Keyword MajorTopicYN="N">children</Keyword><Keyword MajorTopicYN="N">mepolizumab</Keyword><Keyword MajorTopicYN="N">respiratory hypersensitivity</Keyword><Keyword MajorTopicYN="N">severe asthma</Keyword><Keyword MajorTopicYN="N">spirometry</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39337848</ArticleId><ArticleId IdType="pmc">PMC11433087</ArticleId><ArticleId IdType="doi">10.3390/life14091063</ArticleId><ArticleId IdType="pii">life14091063</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Asthma Statistics|AAAAI [Internet]  [(accessed on 25 July 2024)].  Available online:  https://www.aaaai.org/about/news/for-media/asthma-statistics.</Citation></Reference><Reference><Citation>2024 GINA Main Report—Global Initiative for Asthma—GINA [Internet]  [(accessed on 25 July 2024)].  Available online:  https://ginasthma.org/2024-report/</Citation></Reference><Reference><Citation>Senter J.P., Aisenberg L.K., Dudley J.W., Luan X., Huang J., Kenyon C.C., Hill D.A. COVID-19 and Asthma Onset in Children. Pediatrics. 2024;153:e2023064615. doi: 10.1542/peds.2023-064615.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2023-064615</ArticleId><ArticleId IdType="pmc">PMC11035159</ArticleId><ArticleId IdType="pubmed">38606487</ArticleId></ArticleIdList></Reference><Reference><Citation>Jartti T., Gern J.E. Role of viral infections in the development and exacerbation of asthma in children.  [(accessed on 25 July 2024)];J. Allergy Clin. Immunol. 2017 140:895–906. doi: 10.1016/j.jaci.2017.08.003. Available online:  https://pubmed.ncbi.nlm.nih.gov/28987219/</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2017.08.003</ArticleId><ArticleId IdType="pmc">PMC7172811</ArticleId><ArticleId IdType="pubmed">28987219</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L., Pan Y., Zhu Y., Song Y., Su X., Yang L., Li M. Association between rhinovirus wheezing illness and the development of childhood asthma: A meta-analysis.  [(accessed on 25 July 2024)];BMJ Open. 2017 7:e013034. doi: 10.1136/bmjopen-2016-013034. Available online:  https://pubmed.ncbi.nlm.nih.gov/28373249/</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2016-013034</ArticleId><ArticleId IdType="pmc">PMC5387933</ArticleId><ArticleId IdType="pubmed">28373249</ArticleId></ArticleIdList></Reference><Reference><Citation>Corne J.M., Marshall C., Smith S., Schreiber J., Sanderson G., Holgate S.T., Johnston S.L. Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: A longitudinal cohort study.  [(accessed on 25 July 2024)];Lancet. 2002 359:831–834. doi: 10.1016/S0140-6736(02)07953-9. Available online:  https://pubmed.ncbi.nlm.nih.gov/11897281/</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(02)07953-9</ArticleId><ArticleId IdType="pubmed">11897281</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesan P. 2023 GINA report for asthma.  [(accessed on 25 July 2024)];Lancet Respir. Med. 2023 11:589. doi: 10.1016/S2213-2600(23)00230-8. Available online:  https://pubmed.ncbi.nlm.nih.gov/37302397/</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(23)00230-8</ArticleId><ArticleId IdType="pubmed">37302397</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L., Liu H., Ai T., Chen Z., Tang W., Hu S., Hu J. Epidemiology of asthma exacerbation in children before and after the COVID-19 pandemic: A retrospective study in Chengdu, China.  [(accessed on 25 July 2024)];BMC Pediatr. 2023 23:588.  doi: 10.1186/s12887-023-04364-9. Available online:  https://pubmed.ncbi.nlm.nih.gov/37993873/</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12887-023-04364-9</ArticleId><ArticleId IdType="pmc">PMC10664380</ArticleId><ArticleId IdType="pubmed">37993873</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung K.F., Wenzel S.E., Brozek J.L., Bush A., Castro M., Sterk P.J., Adcock I.M., Bateman E.D., Bel E.H., Bleecker E.R., et al.  International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma.  [(accessed on 25 July 2024)];Eur. Respir. J. 2014 43:343–373. doi: 10.1183/09031936.00202013. Available online:  https://pubmed.ncbi.nlm.nih.gov/24337046/</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00202013</ArticleId><ArticleId IdType="pubmed">24337046</ArticleId></ArticleIdList></Reference><Reference><Citation>Robbins E., Daoud S., Demissie S., James P. The impact of asthma on COVID-19 disease severity in children and adolescents.  [(accessed on 25 July 2024)];J. Asthma. 2023 60:1097–1103. doi: 10.1080/02770903.2022.2132956. Available online:  https://pubmed.ncbi.nlm.nih.gov/36200730/</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/02770903.2022.2132956</ArticleId><ArticleId IdType="pubmed">36200730</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui X., Zhao Z., Zhang T., Guo W., Guo W., Zheng J., Zhang J., Dong C., Na R., Zheng L., et al.  A systematic review and meta-analysis of children with coronavirus disease 2019 (COVID-19)  [(accessed on 25 July 2024)];J. Med. Virol. 2021 93:1057–1069. doi: 10.1002/jmv.26398. Available online:  https://pubmed.ncbi.nlm.nih.gov/32761898/</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26398</ArticleId><ArticleId IdType="pmc">PMC7436402</ArticleId><ArticleId IdType="pubmed">32761898</ArticleId></ArticleIdList></Reference><Reference><Citation>Klain A., Indolfi C., Dinardo G., Decimo F., Miraglia Del Giudice M. COVID-19 and spirometry in this age.  [(accessed on 25 July 2024)];Ital. J. Pediatr. 2022 48:11. doi: 10.1186/s13052-022-01199-5. Available online:  https://ijponline.biomedcentral.com/articles/10.1186/s13052-022-01199-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13052-022-01199-5</ArticleId><ArticleId IdType="doi">10.1186/s13052-022-01199-5</ArticleId><ArticleId IdType="pmc">PMC8764647</ArticleId><ArticleId IdType="pubmed">35042531</ArticleId></ArticleIdList></Reference><Reference><Citation>Indolfi C., Izzo L.F., Luciano M., Mercogliano M., Klain A., Dinardo G., Decimo F., Giudice M.M. Impact of reduced COVID-19 restrictions on pediatric recurrent respiratory infections in Southern Italy: A cross-sectional analysis.  [(accessed on 25 July 2024)];Open Explor. 2024 2:340–349. doi: 10.37349/eaa.2024.00049. Available online:  https://www.explorationpub.com/Journals/eaa/Article/100949.</Citation><ArticleIdList><ArticleId IdType="doi">10.37349/eaa.2024.00049</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellegrino R., Chiappini E., Licari A., Galli L., Marseglia G.L. Prevalence and clinical presentation of long COVID in children: A systematic review. Eur. J. Pediatr. 2022;181:3995. doi: 10.1007/s00431-022-04600-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-022-04600-x</ArticleId><ArticleId IdType="pmc">PMC9476461</ArticleId><ArticleId IdType="pubmed">36107254</ArticleId></ArticleIdList></Reference><Reference><Citation>Esposito S., Principi N., Azzari C., Cardinale F., Di Mauro G., Galli L., Gattinara G.C., Fainardi V., Guarino A., Lancella L., et al.  Italian intersociety consensus on management of long covid in children.  [(accessed on 25 July 2024)];Ital. J. Pediatr. 2022 48:42. doi: 10.1186/s13052-022-01233-6. Available online:  https://pubmed.ncbi.nlm.nih.gov/35264214/</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13052-022-01233-6</ArticleId><ArticleId IdType="pmc">PMC8905554</ArticleId><ArticleId IdType="pubmed">35264214</ArticleId></ArticleIdList></Reference><Reference><Citation>Parisi G.F., Diaferio L., Brindisi G., Indolfi C., Umano G.R., Klain A., Marchese G., Ghiglioni D.G., Zicari A.M., Marseglia G.L., et al. Cross-Sectional Survey on Long Term Sequelae of Pediatric COVID-19 among Italian Pediatricians. Children. 2021;8:769. doi: 10.3390/children8090769.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/children8090769</ArticleId><ArticleId IdType="pmc">PMC8467017</ArticleId><ArticleId IdType="pubmed">34572201</ArticleId></ArticleIdList></Reference><Reference><Citation>Umano G.R., Rondinelli G., Rivetti G., Klain A., Aiello F., Miraglia del Giudice M., Decimo F., Papparella A., Miraglia del Giudice E. Effect of COVID-19 Lockdown on Children’s Eating Behaviours: A Longitudinal Study. Children. 2022;9:1078. doi: 10.3390/children9071078.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/children9071078</ArticleId><ArticleId IdType="pmc">PMC9323163</ArticleId><ArticleId IdType="pubmed">35884062</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman N.H.A., Mohd Zahir M.Z., Althabhawi N.M. Repercussions of COVID-19 Lockdown on Implementation of Children’s Rights to Education.  [(accessed on 25 July 2024)];Children. 2023 10:474.  doi: 10.3390/children10030474. Available online:  https://pubmed.ncbi.nlm.nih.gov/36980031/</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/children10030474</ArticleId><ArticleId IdType="pmc">PMC10047681</ArticleId><ArticleId IdType="pubmed">36980031</ArticleId></ArticleIdList></Reference><Reference><Citation>Miraglia del Giudice M., Klain A., Dinardo G., D’Addio E., Bencivenga C.L., Fontanella C., Decimo F., Umano G.R., Siciliano M., Carotenuto M., et al.  Behavioral and Sleep Disorders in Children and Adolescents following COVID-19 Disease: A Case-Control Study.  [(accessed on 25 July 2024)];Children. 2023 10:1189.  doi: 10.3390/children10071189. Available online:  https://www.mdpi.com/2227-9067/10/7/1189/htm.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/children10071189</ArticleId><ArticleId IdType="pmc">PMC10378309</ArticleId><ArticleId IdType="pubmed">37508686</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J., Dong X., Liu G., Gao Y. Risk and Protective Factors for COVID-19 Morbidity, Severity, and Mortality.  [(accessed on 25 July 2024)];Clin. Rev. Allergy Immunol. 2022 64:90–107. doi: 10.1007/s12016-022-08921-5. Available online:  https://link.springer.com/article/10.1007/s12016-022-08921-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-022-08921-5</ArticleId><ArticleId IdType="doi">10.1007/s12016-022-08921-5</ArticleId><ArticleId IdType="pmc">PMC8767775</ArticleId><ArticleId IdType="pubmed">35044620</ArticleId></ArticleIdList></Reference><Reference><Citation>Brindisi G., Zicari A.M., Parisi G.F., Diaferio L., Indolfi C., Marchese G., Ghiglioni D.G., Umano G.R., Klain A., Marseglia G.L., et al. Prevalence of COVID-19 in children affected by allergic rhinoconjunctivitis and asthma: Results from the second “SIAIP rhinosinusitis and conjunctivitis committee” survey. Ital. J. Pediatr. 2022;48:1. doi: 10.1186/s13052-021-01198-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13052-021-01198-y</ArticleId><ArticleId IdType="pmc">PMC8733922</ArticleId><ArticleId IdType="pubmed">34991654</ArticleId></ArticleIdList></Reference><Reference><Citation>Graff K., Smith C., Silveira L., Jung S., Curran-Hays S., Jarjour J., Carpenter L., Pickard K., Mattiucci M., Fresia J., et al.  Risk Factors for Severe COVID-19 in Children.  [(accessed on 25 July 2024)];Pediatr. Infect. Dis. J. 2021 40:E137–E145. doi: 10.1097/INF.0000000000003043. Available online:  https://pubmed.ncbi.nlm.nih.gov/33538539/</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003043</ArticleId><ArticleId IdType="pubmed">33538539</ArticleId></ArticleIdList></Reference><Reference><Citation>Kara A.A., Böncüoğlu E., Kıymet E., Arıkan K., Şahinkaya Ş., Düzgöl M., Cem E., Çelebi M., Ağın H., Bayram S.N., et al. Evaluation of predictors of severe-moderate COVID-19 infections at children: A review of 292 children. J. Med. Virol. 2021;93:6634. doi: 10.1002/jmv.27237.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27237</ArticleId><ArticleId IdType="pmc">PMC8426728</ArticleId><ArticleId IdType="pubmed">34314067</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendes N.F., Jara C.P., Mansour E., Araújo E.P., Velloso L.A. Asthma and COVID-19: A systematic review.  [(accessed on 25 July 2024)];Allergy Asthma Clin. Immunol. 2021 17:5. doi: 10.1186/s13223-020-00509-y. Available online:  https://pubmed.ncbi.nlm.nih.gov/33407838/</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13223-020-00509-y</ArticleId><ArticleId IdType="pmc">PMC7787409</ArticleId><ArticleId IdType="pubmed">33407838</ArticleId></ArticleIdList></Reference><Reference><Citation>Nazif J., Silver E., Okada C., Gross E. Comparison of Children Hospitalized for Asthma Before and During the COVID-19 Pandemic.  [(accessed on 25 July 2024)];Pediatr. Allergy Immunol. Pulmonol. 2022 35:174–178. doi: 10.1089/ped.2022.0115. Available online:  https://pubmed.ncbi.nlm.nih.gov/36537703/</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ped.2022.0115</ArticleId><ArticleId IdType="pubmed">36537703</ArticleId></ArticleIdList></Reference><Reference><Citation>Indolfi C., Klain A., Dinardo G., D’Addio E., Ferrara S., Decimo F., Ciprandi G., Tosca M.A., Miraglia del Giudice M. COVID-19 Pediatric Follow-Up: Respiratory Long COVID-Associated Comorbidities and Lung Ultrasound Alterations in a Cohort of Italian Children.  [(accessed on 25 July 2024)];Children. 2024 11:166.  doi: 10.3390/children11020166. Available online:  https://www.mdpi.com/2227-9067/11/2/166/htm.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/children11020166</ArticleId><ArticleId IdType="pmc">PMC10887372</ArticleId><ArticleId IdType="pubmed">38397278</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed H., Turner S. Severe asthma in children-a review of definitions, epidemiology, and treatment options in 2019.  [(accessed on 25 July 2024)];Pediatr Pulmonol. 2019 54:778–787. doi: 10.1002/ppul.24317. Available online:  https://pubmed.ncbi.nlm.nih.gov/30884194/</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ppul.24317</ArticleId><ArticleId IdType="pubmed">30884194</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciprandi G., Cioffi L., Schiavetti I., del Giudice M.M., Tosca M.A. Factors associated with wheezing recurrence in clinical practice.  [(accessed on 25 July 2024)];J. Asthma. 2022 60:843–844. doi: 10.1080/02770903.2022.2087187. Available online:  https://pubmed.ncbi.nlm.nih.gov/35666209/</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/02770903.2022.2087187</ArticleId><ArticleId IdType="pubmed">35666209</ArticleId></ArticleIdList></Reference><Reference><Citation>Marseglia G.L., Manti S., Chiappini E., Brambilla I., Caffarelli C., Calvani M., Cardinale F., Cravidi C., Duse M., Martelli A., et al.  Chronic cough in childhood: A systematic review for practical guidance by the Italian Society of Pediatric Allergy and Immunology.  [(accessed on 25 July 2024)];Allergol. Immunopathol. 2021 49:133–154. doi: 10.15586/aei.v49i2.44. Available online:  https://pubmed.ncbi.nlm.nih.gov/33641305/</Citation><ArticleIdList><ArticleId IdType="doi">10.15586/aei.v49i2.44</ArticleId><ArticleId IdType="pubmed">33641305</ArticleId></ArticleIdList></Reference><Reference><Citation>Tozzi A.E., Armenio L., Bernardini R., Boner A., Calvani M., Cardinale F., Cavagni G., Dondi A., Duse M., Fiocchi A., et al.  Pediatric allergy and immunology in Italy.  [(accessed on 25 July 2024)];Pediatr. Allergy Immunol. 2011 22:267–276. doi: 10.1111/j.1399-3038.2011.01157.x. Available online:  https://pubmed.ncbi.nlm.nih.gov/21457333/</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-3038.2011.01157.x</ArticleId><ArticleId IdType="pubmed">21457333</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnston N.W., Johnston S.L., Norman G.R., Dai J., Sears M.R. The September epidemic of asthma hospitalization: School children as disease vectors. J. Allergy Clin. Immunol. 2006;117:557–562. doi: 10.1016/j.jaci.2005.11.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2005.11.034</ArticleId><ArticleId IdType="pubmed">16522453</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia G., Taillé C., Laveneziana P., Bourdin A., Chanez P., Humbert M. Anti-interleukin-5 therapy in severe asthma.  [(accessed on 25 July 2024)];Eur. Respir. Rev. 2013 22:251–257. doi: 10.1183/09059180.00004013. Available online:  https://pubmed.ncbi.nlm.nih.gov/23997052/</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09059180.00004013</ArticleId><ArticleId IdType="pmc">PMC9487362</ArticleId><ArticleId IdType="pubmed">23997052</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortega H.G., Liu M.C., Pavord I.D., Brusselle G.G., FitzGerald J.M., Chetta A., Humbert M., Katz L.E., Keene O.N., Yancey S.W., et al.  Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma.  [(accessed on 25 July 2024)];N. Engl. J. Med. 2014 371:1198–1207. doi: 10.1056/NEJMoa1403290. Available online:  https://www.nejm.org/doi/full/10.1056/nejmoa1403290.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejmoa1403290</ArticleId><ArticleId IdType="doi">10.1056/NEJMoa1403290</ArticleId><ArticleId IdType="pubmed">25199059</ArticleId></ArticleIdList></Reference><Reference><Citation>Chupp G.L., Bradford E.S., Albers F.C., Bratton D.J., Wang-Jairaj J., Nelsen L.M., Trevor J.L., Magnan A., Ten Brinke A. Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): A randomised, double-blind, placebo-controlled, parallel-group, multicentre, phase 3b trial.  [(accessed on 25 July 2024)];Lancet Respir. Med. 2017 5:390–400. doi: 10.1016/S2213-2600(17)30125-X. Available online:  https://pubmed.ncbi.nlm.nih.gov/28395936/</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(17)30125-X</ArticleId><ArticleId IdType="pubmed">28395936</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh G.M. Anti-IL-5 monoclonal antibodies for the treatment of asthma: An update.  [(accessed on 25 July 2024)];Expert. Opin. Biol. Ther. 2020 20:1237–1244. doi: 10.1080/14712598.2020.1782381. Available online:  https://pubmed.ncbi.nlm.nih.gov/32529893/</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14712598.2020.1782381</ArticleId><ArticleId IdType="pubmed">32529893</ArticleId></ArticleIdList></Reference><Reference><Citation>Ullmann N., Peri F., Florio O., Porcaro F., Profeti E., Onofri A., Cutrera R. Severe Pediatric Asthma Therapy: Mepolizumab.  [(accessed on 25 July 2024)];Front. Pediatr. 2022 10:920066.  doi: 10.3389/fped.2022.920066. Available online:  https://pubmed.ncbi.nlm.nih.gov/35844748/</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2022.920066</ArticleId><ArticleId IdType="pmc">PMC9283570</ArticleId><ArticleId IdType="pubmed">35844748</ArticleId></ArticleIdList></Reference><Reference><Citation>Bousquet J., Heinzerling L., Bachert C., Papadopoulos N.G., Bousquet P.J., Burney P.G., Canonica G.W., Carlsen K.H., Cox L., Haahtela T., et al.  Practical guide to skin prick tests in allergy to aeroallergens.  [(accessed on 25 July 2024)];Allergy. 2012 67:18–24. doi: 10.1111/j.1398-9995.2011.02728.x. Available online:  https://pubmed.ncbi.nlm.nih.gov/22050279/</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1398-9995.2011.02728.x</ArticleId><ArticleId IdType="pubmed">22050279</ArticleId></ArticleIdList></Reference><Reference><Citation>Ansotegui I.J., Melioli G., Walter Canonica G., Caraballo L., Villa E., Ebisawa M., Passalacqua G., Savi E., Ebo D., Maximiliano Gómez R., et al. IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper. World Allergy Organ. J. 2020;13:100080. doi: 10.1016/j.waojou.2019.100080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.waojou.2019.100080</ArticleId><ArticleId IdType="pmc">PMC7044795</ArticleId><ArticleId IdType="pubmed">32128023</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanojevic S., Kaminsky D.A., Miller M.R., Thompson B., Aliverti A., Barjaktarevic I., Cooper B.G., Culver B., Derom E., Hall G.L., et al.  ERS/ATS technical standard on interpretive strategies for routine lung function tests.  [(accessed on 25 July 2024)];Eur. Respir. J. 2022 60:2101499. doi: 10.1183/13993003.01499-2021. Available online:  https://erj.ersjournals.com/content/60/1/2101499.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01499-2021</ArticleId><ArticleId IdType="pubmed">34949706</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinakar C., Chipps B.E., Matsui E.C., Abramson S.L., Irani A.M., Kim J.S., Mahr T.A., Pistiner M., Wang J., Katkin J.P., et al.  Clinical tools to assess asthma control in children.  [(accessed on 25 July 2024)];Pediatrics. 2017 139:e20163438. doi: 10.1542/peds.2016-3438. Available online:  https://pubmed.ncbi.nlm.nih.gov/28025241/</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2016-3438</ArticleId><ArticleId IdType="pubmed">28025241</ArticleId></ArticleIdList></Reference><Reference><Citation>Agache I., Akdis C.A., Akdis M., Canonica G.W., Casale T., Chivato T., Corren J., Chu D.K., Del Giacco S., Eiwegger T., et al.  EAACI Biologicals Guidelines—Recommendations for severe asthma.  [(accessed on 25 July 2024)];Allergy. 2021 76:14–44. doi: 10.1111/all.14425. Available online:  https://onlinelibrary.wiley.com/doi/full/10.1111/all.14425.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.14425</ArticleId><ArticleId IdType="doi">10.1111/all.14425</ArticleId><ArticleId IdType="pubmed">32484954</ArticleId></ArticleIdList></Reference><Reference><Citation>Parisi G.F., Indolfi C., Decimo F., Leonardi S., Miraglia del Giudice M. COVID-19 Pneumonia in Children: From Etiology to Management.  [(accessed on 25 July 2024)];Front. Pediatr. 2020 8:616622.  doi: 10.3389/fped.2020.616622. Available online:  https://pubmed.ncbi.nlm.nih.gov/33381482/</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2020.616622</ArticleId><ArticleId IdType="pmc">PMC7767924</ArticleId><ArticleId IdType="pubmed">33381482</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardinale F., Ciprandi G., Barberi S., Bernardini R., Caffarelli C., Calvani M., Cavagni G., Galli E., Minasi D., Del Giudice M.M., et al. Consensus statement of the Italian society of pediatric allergy and immunology for the pragmatic management of children and adolescents with allergic or immunological diseases during the COVID-19 pandemic. Ital. J. Pediatr. 2020;46:84. doi: 10.1186/s13052-020-00843-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13052-020-00843-2</ArticleId><ArticleId IdType="pmc">PMC7296524</ArticleId><ArticleId IdType="pubmed">32546234</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaferio L., Parisi G.F., Brindisi G., Indolfi C., Marchese G., Ghiglioni D.G., Zicari A.M., Marseglia G.L., Miraglia Del Giudice M. Cross-sectional survey on impact of paediatric COVID-19 among Italian paediatricians: Report from the SIAIP rhino-sinusitis and conjunctivitis committee.  [(accessed on 25 July 2024)];Ital. J. Pediatr. 2020 46:146. doi: 10.1186/s13052-020-00906-4. Available online:  https://ijponline.biomedcentral.com/articles/10.1186/s13052-020-00906-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13052-020-00906-4</ArticleId><ArticleId IdType="doi">10.1186/s13052-020-00906-4</ArticleId><ArticleId IdType="pmc">PMC7538039</ArticleId><ArticleId IdType="pubmed">33023616</ArticleId></ArticleIdList></Reference><Reference><Citation>Aksu K., Demir Ş., Topel M., Yeşilkaya S., Ateş H., Koca Kalkan İ., Öncül A., Çuhadar Erçelebi D., Türkyilmaz S. COVID-19 in patients with severe asthma using biological agents.  [(accessed on 25 July 2024)];Tuberk. Toraks. 2021 69:433–436. doi: 10.5578/tt.20219721. Available online:  https://pubmed.ncbi.nlm.nih.gov/34581170/</Citation><ArticleIdList><ArticleId IdType="doi">10.5578/tt.20219721</ArticleId><ArticleId IdType="pubmed">34581170</ArticleId></ArticleIdList></Reference><Reference><Citation>Azim A., Pini L., Khakwani Z., Kumar S., Howarth P. Severe acute respiratory syndrome coronavirus 2 infection in those on mepolizumab therapy. Ann. Allergy Asthma Immunol. 2021;126:438–440. doi: 10.1016/j.anai.2021.01.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anai.2021.01.006</ArticleId><ArticleId IdType="pmc">PMC7804376</ArticleId><ArticleId IdType="pubmed">33453381</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>